Related by context. All words. (Click for frequent words.) 84 Hematology Annual Meeting 83 Hematology ASH Annual Meeting 82 Clinical Oncology Annual Meeting 81 Clinical Oncology ASCO 80 Clinical Oncology ASCO Annual 77 Hematology Meeting 73 Cancers Symposium 73 Hematology ASH Meeting 72 Hematology 72 Nephrology Renal Week 70 Clinical Oncology 69 Annual Scientific Sessions 69 Medical Oncology ESMO 69 nd Annual Meeting 69 Clinical Oncology Gastrointestinal Cancers 68 Scientific Session 68 Gastrointestinal Cancers Symposium 68 Scientific Sessions 68 ASH Annual Meeting 67 Digestive Disease Week DDW 67 Connective Tissue Oncology 67 Human Genetics ASHG 67 Clinical Oncologists 67 Neurology AAN 67 Therapeutic Radiology 67 Radiation Oncology ASTRO 66 Microbiology ASM 66 Oncology ASTRO 66 Hypertension ASH 66 Anesthesiologists ASA 65 Digestive Disease Week 65 st Annual Meeting 65 Mass Spectrometry ASMS 65 Clinical Oncology ASCO Gastrointestinal 65 Cancer iSBTc 65 Genitourinary Cancers Symposium 65 Nephrology ASN Renal 64 Gene Therapy ASGT 64 AACR NCI EORTC 64 Pharmaceutical Scientists AAPS 64 AHA Scientific Sessions 64 American Roentgen Ray 64 Rheumatology ACR Annual 64 AACR 64 Mineral Research ASBMR 64 ICAAC 64 Scientific Meeting 64 Cell Biology ASCB 63 ASCO Annual Meeting 63 Society CTOS 63 CTRC AACR San Antonio 63 Anesthesiologists Annual Meeting 63 League Against Rheumatism 63 Cardiology ESC 63 Liver Diseases AASLD 62 Nephrology ASN 62 Breast Cancer Symposium 62 Anesthesiologists ASA Annual Meeting 62 Chemotherapy ICAAC 62 Reproductive Medicine ASRM 62 Stem Cell Research ISSCR 62 Cardiology ACC 62 Echocardiography ASE 62 Liver EASL 62 ASCO Genitourinary Cancers Symposium 61 #th Annual Interscience 61 Interventional Radiology SIR 61 Biological Therapy 61 Neuro Oncology SNO 61 Transcatheter Cardiovascular Therapeutics TCT 61 Cardiology ESC Congress 61 Clinical Chemistry AACC 61 Interventions SCAI 61 Liver Diseases 61 American Thoracic Society 61 AASLD 61 AACR #st Annual Meeting 61 AACR Annual Meeting 61 Therapeutics TCT scientific 60 Breast Surgeons 60 Rheumatology Annual 60 ASCO 60 AACR San Antonio 60 Breast Cancer Symposium SABCS 60 Neurology Annual Meeting 60 Breast Surgeons ASBS 60 Clinical Oncologists ASCO 60 AUA Annual Meeting 60 ASCO GI 60 Nephrology Annual Meeting 60 Antimicrobial Agents 60 Heart Failure Society 60 Cardiovascular Anesthesiologists 60 Neurological Surgeons AANS 60 ADA Scientific Sessions 60 EORTC NCI AACR 60 AACR #nd Annual Meeting 60 Neck Surgery Foundation 60 Prostate Cancer Symposium 59 San Antonio Breast Cancer 59 Ophthalmology AAO 59 EORTC NCI 59 Arteriosclerosis Thrombosis 59 Retina Specialists 59 Gynecologic Oncologists 59 Molecular Targets 59 & Immunology AAAAI 59 EASL 59 ECTRIMS 59 Experimental Biology 59 annual Transcatheter Cardiovascular 59 Gastroenterology ACG 59 Hypertension ESH 59 CROI 58 Digestive Diseases Week 58 Gastrointestinal Endoscopy ASGE 58 ICAAC IDSA 58 Symposium SABCS 58 ASCO GU 58 Diabetes EASD 58 Retina Specialists ASRS 58 System Pharmacists ASHP 58 Heart Rhythm 58 Immunology Annual Meeting 58 Rheumatology ACR 58 ongoing Phase 1b 58 Endovascular Therapy ISET 57 SABCS 57 #st Annual Meeting 57 Medicine SIIM 57 Endocrine Society ENDO 57 Thoracic Surgeons 57 #nd Annual Meeting 57 Toxicology SOT 57 Vascular Annual Meeting 57 Lysosomal Disease Network 57 ISPOR 57 EORTC NCI AACR Symposium 57 Transcatheter Cardiovascular Therapeutics 57 Clinical Pathology ASCP 57 Dermatology AAD 57 Vascular Biology ATVB 57 Cardiology Scientific Sessions 57 Thoracic Surgeons STS 57 AAO HNSF Annual Meeting 57 Liver Disease AASLD 57 ASBMR 57 SUCCEED trial 57 ESMO 57 Surgical Oncology SSO 56 ENDO 56 Cellular Therapy ISCT 56 Late Breaker 56 Ophthalmology ARVO 56 Therapeutic Radiation 56 ECCMID 56 Gynecologic Investigation 56 Clinical Endocrinologists AACE 56 Opportunistic Infections CROI 56 Phase 1b trial 56 Cachexia 56 Gynecologic Oncologists SGO 56 Maternal Fetal Medicine SMFM 56 BIOCOM Investor Conference 56 Rheumatology 56 Gastroenterology ACG Annual 56 Nephrology JASN 56 EULAR 56 Neuropsychopharmacology 56 Hygiene ASTMH 56 Urology EAU 56 Healthcare Epidemiology 56 Therapeutics TCT 56 ASGT 56 Phase 2a trial 56 AABB Annual Meeting 56 Minimally Invasive Cardiothoracic Surgery 55 ARVO 55 Neuro Oncology 55 Midyear Clinical Meeting 55 MOZOBIL 55 American Urological Association 55 EuroPCR 55 Pharmacoeconomics 55 Neurological Surgeons 55 Pediatric Academic Societies PAS 55 AACR Meeting 55 Epilepsy Society 55 #th Interscience Conference 55 America HFSA 55 AAN Annual Meeting 55 ASCO Breast Cancer 55 & OTO EXPO 55 Menopause Society NAMS 55 Controlled Release 55 Nephrology CJASN 54 Lung Transplantation 54 dose escalation clinical 54 Endocrine Society #nd 54 rALLy clinical trial 54 AAPS Annual Meeting 54 Endocrine Society Annual Meeting 54 PROVENGE sipuleucel T 54 CRLX# 54 Phase 2a clinical 54 TG MV 54 Cloretazine ® 54 Transplantation AST 54 Clinical Microbiology 54 Retroviruses 54 BiTE R 54 PROSTVAC TM 54 metastatic castration resistant 54 EULAR Annual 54 Annual Transcatheter Cardiovascular 54 Gastrointestinal Cancer 54 Interscience Conference 54 Pain Medicine AAPM 54 Experimental Biology FASEB 54 ACR ARHP Annual 54 Phase Ib study 54 Cardiovascular Angiography 54 HyQ 54 phase IIb study 53 Medicine AAPM 53 Investigative Dermatology 53 Remote Sensing ASPRS 53 Outcomes Research ISPOR 53 Percutaneous Cardiovascular Interventions 53 Canaccord Adams Hepatitis C 53 ELACYT 53 Clinical Virology Symposium 53 Phase #/#a trial 53 ON #.Na 53 AACR symposium 53 Phase Ib II 53 NASDAQ CYTK announced 53 Clinical Chemistry 53 FDA Oncologic Drugs 53 alvespimycin 53 Applied Spectroscopy 53 Exploration Geophysicists SEG 53 Phase 2b trial 53 Critical Care Medicine 53 European CanCer Organisation ECCO 53 phase IIb clinical 53 vidofludimus 53 Radiologic Technologists ASRT 53 CHEST 53 perifosine 53 SAWC WHS 53 Orthopedic Surgeons AAOS 53 AASLD Meeting 53 rALLy trial 53 Interventional Radiology 53 Paediatric Oncology SIOP 53 ACR ARHP 53 Endoscopic Surgeons SAGES 53 Cardiology 53 BIO InvestorForum 53 #rd Annual CTRC 53 AACR EORTC NCI 53 Experimental Biology EB 53 recurrent glioma 53 Biologic Therapy 53 Inc. Nasdaq OPTR 53 assessing T DM1 53 TACI Ig 52 viral kinetic 52 Cystic Fibrosis Conference NACFC 52 Opportunistic Infections 52 Ophthalmology Annual Meeting 52 #nd EORTC NCI 52 USpella 52 Dermatologic Surgery ASDS 52 pertuzumab 52 International Myeloma Workshop 52 PNP inhibitor 52 ERA EDTA 52 Spine Society 52 HuMax EGFr 52 Chemotherapy ICAAC Infectious Diseases 52 Pediatric Academic Societies 52 Spine Arthroplasty Society 52 ASCO abstract 52 Echocardiography 52 Oncology Nursing 52 CLL8 52 Endocrine Society #st 52 Neurological Surgeons Annual Meeting 52 Immunology AAAAI 52 II Clinical Trial 52 Gastrointestinal Endoscopy 52 Phase 2b study 52 Advanced Neuroendocrine Tumors 52 Phase Ib clinical 52 ASCO Prostate Cancer 52 International Cartilage Repair 52 Brentuximab Vedotin SGN 52 Annual Interscience Conference 52 enzastaurin 52 CCX# 52 Amrubicin 52 Rheumatology Annual Meeting 52 phase IIa clinical 52 abstracts summarizing 52 depsipeptide 52 DDW ® 52 Phase III ALLEGRO 52 Orthopaedic Surgeons AAOS 52 Malignant Lymphoma 52 Solorel TM 52 histone deacetylase HDAC inhibitor 52 PEG SN# 52 recurrent malignant glioma 52 novel VDA molecule 52 Endoscopic Surgeons 52 IRX 2 52 Thoracic Surgery AATS 52 Personalized Immunotherapy 52 Experimental Biology Annual Meeting 52 Nephrology 52 XL# SAR# 52 trastuzumab DM1 T DM1 52 ORAL Sync 52 Equine Practitioners Convention 52 ganetespib 52 phase 2a 52 Infectious Diseases ECCMID 52 Alzheimer Disease ICAD 52 CR# vcMMAE 52 preclinical efficacy 51 Phase 2a 51 ASTRO Annual Meeting 51 zanolimumab 51 Immunologists 51 phase IIb trial 51 SCAI Annual 51 NASDAQ SLXP today 51 Hyperthermic Oncology ESHO 51 phase IIb 51 Targeted Anticancer Therapies 51 CRMD# 51 GRN#L 51 Plant Biologists ASPB 51 Respiratory Society 51 Carfilzomib 51 Plastic Surgeons ASPS 51 Endovascular Therapy 51 Antimicrobial Chemotherapy 51 HIF PHI 51 registrational Phase 51 Clinical Dermatology 51 relapsed multiple myeloma 51 Phase #b/#a clinical 51 Bariatric Physicians ASBP 51 Nordic ACTI 51 Diabetic Macular Edema 51 EORTC 51 System Pharmacists Midyear 51 Roentgenology 51 evaluating tivozanib 51 AEG# 51 UEGW 51 Cellular Therapy 51 IL# PE#QQR 51 Orthopaedic Surgeons Annual Meeting 51 randomized Phase III 51 Association Executives ASAE 51 APOPTONE 51 Investigative Pathology 51 acute PAO 51 Tanespimycin 51 NASDAQ CXSP announced 51 mCRC patients 51 HQK 51 Chemophase 51 Golf Course Architects ASGCA 51 Immunology ACAAI 51 Antiviral Research 51 MEND CABG 51 Annual ICAAC 51 elotuzumab 51 Hand ASSH 51 Addiction Medicine ASAM 51 ILLUMINATE 51 Canaccord Adams Musculoskeletal 51 Bariatric Surgery ASBS 51 HuMax CD4 51 Therapeutic Radiation Oncology 51 Information Display SID 51 forodesine 51 Integrative Oncology 51 CBLC# 51 Neuromodulation Society 51 Chicago Multidisciplinary Symposium 51 relapsed refractory multiple myeloma 51 oral ridaforolimus 51 bazedoxifene conjugated estrogens 51 pan HDAC inhibitor 51 Neuropsychopharmacology ACNP 51 recurrent glioblastoma 51 Phase 1b 51 epigenetic therapies 51 American Gastrointestinal Endoscopic 51 multicenter Phase 51 Hsp# Inhibitor 50 SPIRIT IV 50 Vascular Biology 50 Annual BIO 50 obatoclax 50 www.aacr.org 50 HORIZONS AMI trial 50 taxane resistant 50 oral FTY# 50 SCCHN 50 ® DDW 50 NO# [002] 50 fidaxomicin Phase 3 50 Plicera 50 Prostate AdenoCarcinoma Treatment 50 Gaylord Palms Hotel 50 Phase Ib 50 clinical pharmacology studies 50 sipuleucel T 50 Biomolecular Sciences SBS 50 dose escalation trial 50 RGB # 50 huC# DM4 50 Ophthalmology ARVO Annual Meeting 50 oral prodrug 50 Surgeons ACS 50 Cardiovascular Computed Tomography 50 perifosine KRX 50 Apoptone 50 Colposcopy 50 picoplatin 50 Haemostasis ISTH 50 HCV polymerase inhibitors 50 ENDEAVOR III 50 Biotech Showcase 50 ISHLT 50 Zenvia Phase III 50 CIMZIA ™ 50 Traficet EN 50 Aesthetic Mesotherapy 50 multiple myeloma MM 50 COU AA 50 HCV SPRINT 50 Nasdaq DNDN 50 ADVANCE PD 50 BioPharm America 50 ImmunoVEX HSV2 50 Cervical Pathology 50 metaglidasen 50 Inflammatory Bowel Diseases 50 Thoracic Oncology 50 PRNewswire FirstCall Genta Incorporated 50 registrational 50 vascular disrupting agent 50 Ampligen ® 50 INCB# [001] 50 Plastic Surgeons ASPS Plastic 50 SAR# [004] 50 AACR Frontiers 50 HUPO 50 blinatumomab 50 PROSTVAC VF 50 riociguat 50 EGEN 50 ZYBRESTAT 50 Breaking Clinical Trials 50 Postgraduate Course 50 anti arrhythmic drug 50 Phase III psoriasis 50 Atrial Fibrillation Symposium 50 FOLOTYN ® 50 alvimopan 50 CYT# potent vascular disrupting 50 bortezomib Velcade 50 transthyretin TTR mediated amyloidosis 50 mCRC 50 Nasdaq ENZN 50 TXPO 50 HFSA Annual 50 Gynecologic Cancer Society 50 heavily pretreated 50 PXD# 50 atacicept 50 Dacogen injection 50 oral proteasome inhibitor 50 American Physiological Society 50 EOquin TM 50 aliskiren 50 atypical Hemolytic Uremic Syndrome 50 Combination REOLYSIN R 50 SYNTAX trial 50 ASCO Gastrointestinal Cancers Symposium 50 KRN# 50 ZYBRESTAT fosbretabulin 50 ALN TTR 50 Phase IIB 50 EXPAREL ™ 50 Molecular Medicine Tri 50 Global Healthcare Unplugged 50 Inc. Nasdaq AMLN 50 ROCKET AF 50 Microbiology 50 International Papillomavirus 50 CALGB # [002] 50 Liver Meeting 50 FOLOTYN 50 Gastroenterology 50 NEUVENGE 50 American Psychosomatic Society 50 trabectedin 50 Regional Anesthesia 50 placebo controlled clinical 49 INSPIRE Trial Phase III 49 Neurology AAN Annual Meeting 49 Announces Poster Presentations 49 Movement Disorder 49 Ceflatonin 49 Urocortin 2 49 Vascular Surgery SVS 49 Agennix AG FRANKFURT AGX 49 YONDELIS 49 anticancer compound 49 JAK1 49 phase IIa 49 pralatrexate 49 multicenter trials 49 HORIZONS AMI 49 oral rivaroxaban 49 SAEM Annual Meeting 49 Biomolecular Sciences 49 Chronic Lymphocytic Leukemia 49 decitabine 49 Chest Physicians CHEST 49 Jupiter Tequesta Orchid 49 Randomized Phase 49 lintuzumab 49 Nasdaq MBRX announced 49 huN# DM1 49 Refractive Surgery ASCRS 49 chronic lymphocytic leukemia CLL 49 Paediatric Endocrinology 49 Professional Sleep Societies 49 Diabetologia 49 Pirfenidone 49 recurrent GBM 49 CoFactor 49 CTAP# Capsules 49 resistant ovarian cancer 49 BCIRG 49 Clinical Oncology JCO 49 AIR2 Trial 49 Marrow Transplantation 49 Sym# 49 Transplant Surgeons ASTS 49 Omacetaxine 49 preclinical pharmacokinetic 49 Adolescent Medicine SAM 49 Pediatric Otolaryngology 49 Hedgehog Pathway Inhibitor 49 NCCN Clinical Practice 49 HIMSS Healthcare 49 Maternal Fetal Medicine 49 International OARSI 49 HCV NS5B polymerase 49 Nuclear Cardiology 49 ECCO ESMO 49 Experimental NeuroTherapeutics 49 AAAAI Annual Meeting 49 evaluating REVLIMID 49 axitinib 49 histone deacetylase inhibitor 49 EVEREST II 49 FOLFOX6 chemotherapy regimen 49 fosbretabulin 49 PERSEUS 49 Liver Disease 49 ASN Renal Week 49 America RSNA 49 J. Mazzo Ph.D. 49 Asthma Allergy 49 radezolid 49 CIMZIA TM certolizumab pegol 49 PEGylated interferon beta 1a 49 Inc. NASDAQ HEPH 49 varespladib 49 PSN# [002] 49 PANVAC VF 49 Azedra 49 mitogen activated ERK kinase 49 Headache Society 49 Nanomedicine ASNM 49 CALGB 49 Metastatic Melanoma 49 mRCC 49 Aesthetic Plastic Surgery ISAPS 49 INCB# [002] 49 voreloxin 49 Cell Therapy 49 Lymphoseek ® 49 MERLIN TIMI 49 maximally tolerated dose 49 PFO migraine 49 preclinical 49 neratinib 49 Neurological Societies 49 novel histone deacetylase 49 amrubicin 49 Cloretazine R 49 Minimally Invasive Gynecology 49 Microplasmin 49 teriflunomide 49 randomized controlled Phase 49 pharmacokinetic PK 49 metastatic CRC 49 Natalizumab 49 HER2 positive metastatic breast 49 Malignant Mesothelioma 49 palifosfamide 49 BRIM3 49 Nuclear Cardiology ASNC 49 Rheumatology EULAR 49 Quinamed 49 Cardiology JACC 49 APPRAISE 49 LUX Lung 49 Chemical Society 49 OXi# 49 Phase III placebo controlled 49 metastatic renal cell carcinoma 49 PRNewswire FirstCall Amylin Pharmaceuticals 49 Dermatology Annual Meeting 49 www.asco.org 49 Oral Fingolimod 49 Cloretazine R VNP#M 49 catheter occlusion 49 CLARITY study 49 interferon gamma 1b 49 Arch Surg 49 ENESTnd 49 QLT# 49 ExTRACT TIMI 49 docetaxel chemotherapy 49 drug eluting stent DES 49 MTT S 49 Lung Transplantation ISHLT 49 entitled Synergistic 49 Xanafide 49 Cambridge Healthtech Institute 49 Nasdaq IDRA today 49 System Pharmacists 49 DU #b 49 phase Ib 49 relapsed refractory 48 VEITHsymposium 48 relapsing remitting multiple sclerosis 48 International Neuropsychological Society 48 Phase 2b 48 Marine Mammalogy 48 Romiplostim 48 chemotherapy gemcitabine 48 targeting CD# 48 MLN# 48 Gynecologic Oncology Group 48 TASKi2 48 Urologic Oncology SUO 48 Phase IIB clinical 48 Inc. Nasdaq VRUS 48 Gemzar ® 48 Aflibercept 48 CTRC AACR 48 HGS ETR1 48 Paediatric Infectious Diseases 48 ProSavin 48 CUSTOM III 48 Abstract # 48 sulodexide 48 eniluracil 48 Cotara 48 E CENP E 48 Cardiology Heart Failure 48 Oncologic Drugs Advisory 48 vinca alkaloid 48 Aesthetic Plastic Surgery ASAPS 48 HepaSphere 48 cetuximab Erbitux 48 Haematology 48 BiTE ® 48 randomized multicenter trial 48 Venous Forum 48 Fifth Decennial International 48 Education ISTE 48 galiximab 48 Active Biotech NASDAQ OMX 48 randomized Phase IIb 48 metastatic hormone refractory 48 Gene Therapy 48 th Interscience Conference 48 GTCbio 48 Arthroscopy Association 48 Neurology 48 PRECISE 48 Hepatology journal 48 satraplatin Phase 48 dasatinib Sprycel 48 AVADO 48 ENDEAVOR IV 48 EFNS 48 TMC# C# 48 Physiology Regulatory Integrative 48 Allergy Asthma 48 randomized Phase 2b 48 ponatinib 48 Phase #/#a 48 Molecular Pathology AMP 48 Wound Healing Society 48 CYT# 48 Clinical Psychopharmacology 48 ALN VSP 48 rivaroxaban Xarelto 48 Aplidin R 48 ABSORB 48 prostate cancer mCRPC 48 Medical Oncology 48 GASTRO 48 Experimental Therapeutics 48 AVERROES 48 PRNewswire FirstCall Genaera 48 CEQ# 48 Phase 2b Clinical Trial 48 CA4P 48 entinostat 48 non nucleoside inhibitor 48 refractory chronic myeloid 48 DDW 48 GVAX ® 48 OncoVEX GM CSF 48 Oncology ESTRO 48 Val HeFT 48 Experimental Hematology 48 Bioral ® 48 essential thrombocythemia ET 48 Oak Brook Ill. RSNA.org 48 Anti Infective Drugs 48 ACC.# 48 Cardiostim 48 AQ4N 48 PRNewswire FirstCall Tercica 48 liposome injection 48 TRO# 48 ThermoDox ® clinical 48 MEND CABG II 48 FIP Pharmaceutical 48 Thrombosis 48 PRIMO CABG2 48 JAK2 inhibitor 48 EASD 48 Mammalogists 48 Safety Engineers ASSE 48 AP# [003] 48 Clinical Trial Results 48 adecatumumab 48 Phase Ib clinical trials 48 Cardiovascular Therapeutics 48 sorafenib tablets 48 rALLy 48 delafloxacin 48 verteporfin 48 iclaprim 48 Preclinical Data 48 Rhinology 48 pharmacokinetic PK study 48 Blinatumomab 48 BioNumerik 48 Dermatological Surgery 48 Venereology EADV 48 seliciclib CYC# 48 mGluR5 negative 48 alpha antagonist 48 MT#/MEDI-# 48 ABRF 48 Talabostat 48 sunitinib malate 48 antibody MT# 48 Belimumab 48 Nasdaq PCYC 48 Society HIMSS 48 HGS# 48 Elagolix 48 Related Disorders ICAD 48 Optical Engineering 48 plus Copegus R 48 EUROGIN 48 RECIST Response Evaluation Criteria 48 Acute MI 48 BioProcess International 48 ASMS Conference 48 Biological Psychiatry 48 OvaRex R 48 clinical trial 48 Cardiovascular Disease Epidemiology 48 MATCHED 48 Neuropathic Pain 48 R roscovitine 48 Clinical Trials Update 48 Physiology Renal Physiology 48 anti angiogenic therapy 48 Aplidin 48 Menopause Society 48 AS# amonafide L malate 48 HDL Mimetic Peptide 48 Cancer Therapeutics 48 International Verapamil SR 47 Group RTOG 47 periOperative Registered Nurses AORN 47 vivo efficacy 47 PITTCON 47 GRNCM1 47 tanespimycin 47 Poster Discussion 47 brivaracetam 47 candidate epratuzumab 47 BRIM2 47 cediranib 47 DASISION 47 Zarnestra 47 gastrointestinal stromal tumors GIST 47 Radiation Therapy Oncology 47 Daniel Von Hoff 47 Dasatinib 47 Hair Restoration Surgery 47 Annual Institutional Investor 47 KRAS status 47 Dermatology Physician Assistants 47 coronary stent merged 47 Multiple Sclerosis ECTRIMS 47 BiTE antibody 47 J Clin Oncol 47 oral Xeloda 47 Anesthesiologists 47 Geriatric Psychiatry 47 Intraoperative Surgical Planning 47 Hsp# inhibitor 47 standard chemotherapy regimen 47 Leukocyte Biology 47 Reproductive Medicine specify 47 Hydroxyurea 47 Cardiovascular Interventions 47 Neuroradiology 47 LBH# 47 Healthcare Publication Editors 47 Radiology Imaging Network ACRIN 47 compound AEZS 47 Diabetes EASD Annual Meeting 47 PERSEUS clinical program 47 HIF PH inhibitors 47 Human Brain Mapping 47 ESTRO 47 Society Nephrology CJASN 47 ORMD 47 Interventional Pain Physicians 47 hematologists 47 LymphoStat B 47 substudy 47 lupus nephritis 47 ZOLINZA 47 PRNewswire FirstCall Ardea Biosciences 47 journal Arteriosclerosis Thrombosis 47 MT# MEDI 47 Gynecologic Oncology 47 multicenter Phase II 47 carfilzomib 47 ThinkEquity Partners Growth 47 elacytarabine 47 ® cetuximab 47 Radiology ECR 47 Nexavar sorafenib 47 Therapeutics Roundtable 47 Geriatric Oncology 47 Dr. Gulfo 47 sapacitabine 47 randomized discontinuation trial 47 BR.# 47 Neurochemistry 47 RECORD1 47 Lung Cancer IASLC 47 Chronic Lymphocytic Leukemia CLL 47 J Clin Endocrinol Metab 47 antithrombotic therapies 47 Obesity NAASO 47 HRPC 47 Female Urology 47 ASH Abstract # 47 Acute Heart Failure 47 ECNP 47 metastatic melanoma 47 LibiGel ® 47 Perifosine 47 J Natl Cancer Inst 47 Medicine NEJM 47 ISTH 47 RE LY trial 47 Ceflatonin R 47 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 47 immunotherapeutic agent 47 PROTECT II 47 Investor Luncheon 47 clevidipine 47 ANTEGREN 47 Artificial Organs 47 Ocular Inflammation 47 Tesetaxel 47 Environ Health Perspect 47 Archexin 47 Gynecological Oncologists 47 PROSTASCINT R 47 number NCT# ClinicalTrials.gov 47 ISTODAX ® 47 midstage clinical 47 scientific journal Proceedings 47 multicenter clinical 47 Solid Tumors 47 PI3 kinase inhibitors 47 Surgery ASLMS 47 Bariatric Surgery ASMBS 47 Oligonucleotide Therapeutics Society 47 Chest Pain Centers 47 Annual Meeting 47 Endocrine Society 47 periOperative Registered Nurses 47 Inc. Nasdaq IMGN 47 Initiated Phase 47 Dr. Yatscoff 47 Thoracic Surgery 47 Onrigin 47 lexidronam injection 47 EchoCRT 47 deforolimus 47 Pediatric Radiology 47 NYSE Amex HEB 47 orally administered inhibitor 47 Selective Cardiac Myosin 47 relapsing multiple sclerosis 47 Ambrisentan 47 HDL Selective Delipidation 47 Certican 47 MGd 47 Xelox 47 Lenocta 47 journal Antimicrobial Agents 47 Preclinical Study 47 tolerability profiles 47 Canaccord Genuity Musculoskeletal 47 Neurological Surgeons CNS 47 orally inhaled migraine 47 LibiGel Phase III 47 Nasdaq SGMO announced 47 antibody blinatumomab MT#/MEDI-# 47 Inc. NASDAQ NBIX 47 Phase III AFFIRM 47 Clinical Endocrinologists 47 Arch Neurol 47 Respiratory Care AARC 47 IRESSA 47 Nasdaq OPTR 47 AAG geldanamycin analog 47 proteasome inhibitor 47 PreCISe 47 phase IIIb 47 Am J Pathol 47 Pediatric Academic Society 47 IMGN# 47 iSBTc 47 Center ™ NGDC 47 Ambulatory Anesthesia 47 RIO Lipids 47 Kahalalide F 47 Romidepsin 47 Infectious Diseases Society 47 Ranolazine 47 LymphoStat B TM 47 AA Amyloidosis 47 DAVANAT 47 BiTE antibody MT# 47 Clin Chem 47 Plastics Engineers SPE 47 Inc. Nasdaq ATHX 47 hormone refractory metastatic prostate 47 CARE HF 47 CTI Nasdaq 47 PRNewswire FirstCall Poniard Pharmaceuticals 47 Multiple Myeloma MM 47 PSMA ADC 47 Proc Am Soc